Return to site

Live Cell Imaging Market Trends Estimates High Demand by 2023

The global Live Cell Imaging Market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9%.

Growth in the live cell imaging market can primarily be attributed to various factors such as the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research.

Market Size
The global Live Cell Imaging Market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9%.
To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198630754
“By type, the microscopes segment is estimated to hold the largest share of the live cell imaging instruments market”
Based on type, the market is segmented into microscopes, standalone systems, cell analyzers, and accessories. In 2018, the microscopes segment accounted for the largest share of the live cell imaging instruments market. Increasing studies into cell behavior and the need to correlate multiple events and markers with cell morphology, favorable funding scenario for R&D in microscopy, rising focus on regenerative medicine, technological advancements in microscopes, and favorable regulatory procedures in order to launch new instruments in the market are the key factors driving the growth of the microscopes market.
“By type, the reagents segment is estimated to hold the largest share of the live cell imaging consumables market”
On the basis of type, the global live cell imaging consumables market is segmented into reagents, media, assay kits, and other consumables (microplates, slides, petri dishes, cover slips, and culture chambers). In 2018, the reagents segment accounted for the largest share of the consumables market. The large share of this segment can be attributed to the growing applications of biosciences and biotechnology within the pharmaceutical and healthcare fields.

Recent Developments

  • Leica Microsystems (a subsidiary of Danaher Corporation) entered into an agreement with Triolab AS, a leading distributor of diagnostics and life science products.
  • In September 2018, Leica signed an agreement with Triolab to enable the latter supply and support Leica Microsystems’ confocal, and stereo microscope systems for the life science industry and sample preparation products for electron microscopy.
For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=163914483
All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly